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More  than  a  decade  ago  it  was  recognized  that  ACTH  and  cortisone 
ameliorate some hemolytic anemias in man (1-6). Nevertheless, the mechanisms 
responsible for their therapeutic effect have not been elucidated. It is generally 
believed that cortisone and its analogues benefit only those hemolytic anemias 
in which the red cells can be agglutinated by Coombs (antiglobulin) serum. 
Indeed, of the many published case reports  (7, 8) there is but one well docu- 
mented  study  (9)  indicating  that  cortisone  administration  may  benefit  a 
"Coombs-negative" hemolytic disease, hereditary spherocytosis. 
Agglutination of red cells by Coombs serum indicates the presence of protein, 
usually a globulin, attached to the cell surface. Although it has been demon- 
strated that red cells may be agglutinable in Coombs serum as a result of the 
non-immunologic adherence of protein (10--13), it is probable that the globu- 
lins attached to red cells in most cases of "Coombs-positive" hemolytic anemia 
are specific antibodies directed against either exogenous haptens such as drugs 
(14, 15) or endogenous stromal antigens (16-19). This adherence of antibody to 
red cells may provoke hemolysis in vivo by causing complement fixation thereby 
resulting in direct cellular damage (20),  or more often indirectly by causing 
red cell sequestration and destruction in the spleen or liver  (21,  22).  Theo- 
retically, cortisone might suppress the injurious effects of antibodies on red cells 
in the following ways: (a) By decreasing the synthesis of antibody (23, 24),  (b) 
by interfering with antigen-antibody union (25, 26),  and (c) by inhibiting the 
consequences of this union (27-29). In the past each of these has been invoked to 
explain the salutary effects of steroid therapy in acquired hemolytic anemia. 
Recently we have attempted to define the role of reticnloendothelial function 
in  erythroclasia.  Rats  were  injected with  a  variety of  "reticnloendothelial- 
blocking" substances in an effort to modify the sequestration of red cells pre- 
viously altered in vitro by sensitization with antiserum or by prolonged sterile 
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incubation  at  37°C.  The  destruction  of  these  altered  cells  was  compared  in 
groups of normal and treated animals.  Of the agents studied,  cortisone proved 
the most interesting.  A  preliminary report of  our findings has  been  published 
(30). 
Methods 
The techniques employed have been described fully in a previous publication (31) and are 
summarized below. 
A. Sensitization of Red Cells.--Rat  red cells obtained from freshly defibrinated blood were 
labeled with Cr  61 of high specific  activity  I in the form of Na2Cr510,  (5 to 10 microcuries per 
ml of defibrinated blood), centrifuged, and washed once in excess saline to remove unbound 
chromium. To a  50 per cent saline suspension of labeled ceils was added an equal volume of 
an  appropriate  concentration of  rabbit anti-rat-red cell  antiserum  (previously heated  for 
2 hours at 56°C). The sensitizing and agglutinating characteristics of this antiserum had been 
determined previously. After incubation in antiserum for 1 hour at 37°C,  the cells were sep- 
arated by centrifugation, washed once in excess saline, and brought to a  40 per cent packed 
red cell volume with fresh rat serum. In such cell preparations frank agglutination was de- 
fined as red cell agglutination which persisted on suspension of the cells in a  large (1:100) 
volume of saline. Increased agghitinability was determined, in most instances by the Coombs 
technique  (32)  employing  rat  antiserum,  and  in  all  instances  with  polyvinylpyrrolidone 
(P.V.P.)  (33). 
B.  Incubation of Red Cells at 37°C.--Rat blood was defibrinated using sterile precautions 
and was incubated for 21 hours at 37°C; thereafter, the cells were labeled with Cr  51, washed 
in saline, and suspended as a  40 per cent red cell concentration in fresh rat serum as pre- 
viously described. 
C.  Preparation of Radioactive Hemoglobin.--Red cells obtained from a  normal donor rat 
were labeled with Cr  51, washed in saline, and lysed in distilled water.  The hemolysate was 
buffered (pH 7.6)  and Seitz-filtered to remove the stroma. 
D. Subjects.--The  recipient animals were  large  (400  to  525  gin),  Bartonella-free, white 
male Sprague-Dawley rats of a  Caesarian-derived strain3  They were paired by weight, and 
one of each pair received daily for 6  days an intramuscular injection of cortisone acetate,* 
10 mg in 0.4 ml of physiologic saline. The paired  control animal received 0.4 ml of saline 
alone. Every rat was weighed daily at the time of injection. 
E. Studies in  Vivo.--In  most  experiments  4  animals  were  studied  simultaneously--2 
cortisone-treated rats with paired,  normal controls. Occasionally accidental death occurred 
during experimental procedures.  This resulted  in unequal  numbers of  animals within  the 
various groups studied and complicated somewhat statistical analysis of the data obtained. 
By intravenous injection into a  tail vein, the recipient animals received  (a) 0.5 ml. of the 
previously prepared 40 per cent suspension of Cral-labeled sensitized or incubated red cells 
or  (b)  0.8 ml of the Cr~l-labeled  hemoglobin solution containing 2.5 mg of hemoglobin (an 
amount calculated not to exceed the binding capacity of circulating haptoglobin). 
After injection of the labeled material, tail puncture was performed distal to  the site of 
injection at  specified time intervals. Two  0.1  ml blood  samples were  obtained and added 
quantitatively  to  1.0  ml  of  water  and  to  1.0  ml  of  heparinized  saline  respectively. 
The heparinized saline samples were centrifuged for 5 minutes at  1800  RPM and 0.5 m] of 
the supernatant was removed for measurement of plasma radioactivity. Every animal was 
1300 to 500 mc per rag; Abbott Laboratories, North Chicago. 
2 Charles River Laboratories, Boston. 
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sacrificed by cervical dislocation approximately 3 hours after injection of the cells. The spleen, 
liver, lungs, left kidney, and right femur were dissected cleanly, rinsed in saline, and blotted 
gently with gauze sponges before being weighed. The Cr  51 of whole blood, plasma, and of 2 
gin or less samples of the dissected organs were measured in a well-type scintillation counter 
for a  minimum of  10,000  counts. 
F.  Calculations.--The concentration of red cell Cr  51 activity in whole blood immediately 
after injection was estimated from the following equation: 
Cr  51 inj 
(Cr~%)to  = 
B1 vol ' 
where 
(Cr  5' ~) to represents the Cr  61 activity in counts per minute per milliliter whole blood  at 
time 0 after injection 
Cr  ~1 inj represents total Cr  s~ activity injected in counts per minute 
B1 vol represents estimated blood volume 
Measurements of total blood volume utilizing a  Cr~'-labeled red cell dilution technique in 
5 rats (similar in size and age to those studied) before and after 6 days of cortisone therapy 
revealed that, in untreated animals, total blood volume in  milliliters averaged 4.46 per cent 
(± 0.25 per cent) of body weight in grams. After cortisone therapy the  mean blood volume 
was increased slightly to 4.74 per cent (-4- 0.31 per cent) of body weight (0.1  >  p  >  0.05). 
Consequently,  these two percentages  were used  to  estimate total blood volume in control 
and cortisone-treated animals respectively. 
The percentage of infused red cell Cr  tl activity remaining in the circulation at a given time 
after  injection was  calculated  from  the  following expression: 
(Cr51~)to 
where 
(Cr51wb)t~  represents  the total  Cr  51 activity  in counts per minute per ml whole blood at 
time x. 
(Crtlp/)t, represents the plasma Cr  t~ activity in counts per minute per ml blood at  time x. 
The Cr  t~ activities of the extirpated organs were calculated as (a) percentage of total Cr  sl 
activity injected, and  (b)  percentage of  total injected Cr  ~  activity contained per  gram of 
organ. 
As it had been shown previously (31)  that the amount of antiserum employed to sensitize 
red cells determines the rate and site of their sequestration, it was presumed that different 
mechanisms were responsible for cellular trapping and destruction dependent upon the in- 
tensity of immunologic injury produced. We wished to observe the effect of steroid administra- 
tion on each of these destructive mechanisms; consequently,  the sequestration of red ceils 
sensitized to varying degrees was studied in several small groups of normal and cortisone- 
treated animals. In order to allow adequate statistical evaluation of the resultant data, the 
technique of anaiysis of variance (34,  35) was utilized. In contrast, the incubated red ceils 
and hemoglobin solutions were prepared in a  standardized fashion resulting in uniformity of 
the infusates. Sufficiently large groups of treated and control recipient animals were studied to 
allow statistical evaluation of the data obtained by means of the "t test" (34). 
RESULTS 
A. Observations in Vitro 
1.  Sensitized Red Cells.--The addition  of various  quantities  of rabbit  anti- 
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Coombs serum and to polyvinlylpyrrolidone (P.V.P.) without agglutination at 
relatively small concentrations of antiserum; (b) red cell agglutination at moder- 
ate concentrations of antiserum; and (c) traces of hemolysis, occurring only in 
the presence of a large volume of fresh rat serum as a source of complement, at 
relatively large  concentrations of antiserum.  When  still larger quantities  of 
antiserum  (ratio antiserum/red cell >  1.0)  were employed in  an  attempt  to 
produce more intense red cell sensitization, frank intravascular hemolysis en- 
sued on subsequent injection of these cells into the recipients. This was indicated 
by unusually high  Cr  sl  activities in the plasma  and kidneys.  Since here the 
sequestration  of labeled red  cells was  obscured by a  concomitant release of 
labeled hemoglobin, these data will not be considered. 
2.  Incubated Red Cells.--Sterile incubation of rat blood for 21 hours at 37°C 
resulted in brownish discoloration of the red cells caused by methemoglobin 
TABLE I 
The Effect of Rabbit Antiserum on Rat Red Cells in Vitro 
Rabbit antiserum (ml) 
Rat red cells (ml) 
0.00 
0.17 
0.33 
0.50 
1.00 
Hemolysis in fresh serum 
0 
0 
0 
0 
Trace 
In serum 
0 
0 
1+ 
2+ 
3+ 
Agglutination 
InP.V.P. 
0 
3+ 
4+ 
4+ 
4+ 
formation.  On  subsequent manipulation  of the  cells prior to  injection some 
hemolysis invariably occurred. 
3.  Cr51-Labeled  Hemoglobin.--The absence of cellular particles and of hemo- 
globin crystals was verified microscopically before injection. 
B. Observations in Vivo 
1.  Sensitized Red Cells.--A previous publication describes the kinetics of im- 
mune red cell destruction in normal rats  (31).  The rate  of disappearance of 
such  red  cells  from  the  circulation  was  found  to  be  directly  related  to 
the quantity of sensitizing antiserum employed. At concentrations of antisera 
producing little or no agglutination in vitro (ratios of antiserum to packed red 
cells of 0.17  to 0.33), red cell destruction was relatively slow and incomplete 
with splenic sequestration predominating. With higher ratios of antiserum to 
red cells (0.50 to 1.00)  hepatic sequestration became prominent while the effi- 
ciency of splenic trapping diminished.  Only at frankly lytic concentrations of 
antiserum (ratios of antiserum to red cells of greater than 1.00) did significant 
(> 1 per cent) Cr  ~1 activity accumulate in the kidneys of the recipient animals. MANUEL  E.  KAPLAN  AND  JAMES  H.  JANDL  925 
No significant uptake of Cr  5x activity by the lungs or femurs of the recipients 
could be detected at any level of red cell sensitization. 
In cortisone-treated rats the disappearance of sensitized red cells,  at each 
level of red cell sensitization studied, was slower than that in control animals. 
Because of the complex character of the survival curves, no attempt was made 
to analyze rate constants. However, the data relating to red cell survival 3 hours 
after injection of cells  (Table II, Fig.  1)  were analyzed statistically and the 
TABLE  II 
The Effect of Cortisone on the Sequestration of Sensitized Red Cells 
No. animals 
Antiserum i  studied 
(ml) 
(ml) 
Igor-  Corti- 
real  sone 
0.00  3  3 
0.17  2  4 
O. 33  2  2 
O. 50  5  7 
1.00  3  2 
Total  15  18 
Circulating red 
cell Cr  sl 
activity per 
cent injected 
Nor-  Corti- 
nml  sone 
93.0  93.0 
4-9.1  -4-4.6 
54.2  69.2 
-4-1.6  -4-7.9 
36.7  45.0 
4-6.3  -*4.0 
19.9  42.6 
-.13.1  4-12.8 
0.8  12.8 
4-0.6  -*4.6 
Hepa  t ipCr:leatC  ~iectcte~ 3 hrs., 
Total  Per gm 
Nor-  Corti- 
mal  sone 
3.5  4.5 
4-0.4  -.1.2 
12.4  7.4 
-*3.O  -4-2.6 
24.4  18.6 
4-3.2  -4-1.8 
48.1  21.8 
-.11.2  -4-6.9 
77.0  55.6 
-*5.9  -4-18.3 
Nor-  Cortl- 
msl  sone 
0.26  0.27 
4-0.04  -4-0.05 
0.92  0.50 
4-0.18  -4-0.166 
1.74  1.19 
-;-0.24  -4-0.14 
3.08  1.35 
4-0. 735  -4-0.357 
4.79  3.22 
4-0.381  -*0.885 
Splenic Cr  u  activity at 3 hrs., 
per cent injected 
Total  Per gm 
Nor-  Corti- 
real  sone 
1.0  0.9 
-*0.2  -*0.2 
24.1  31.3 
4-0.7  -.11.8 
38.8  40.6 
-4-4.8  -.10.0 
30.4  47.8 
4-2.6  -4-22.1 
7.0  86.6 
-4-2.3  4-12.6 
Nor-  Corti- 
real  sone 
! 
0.8  0.5 
-*o.2  I  4-o.1 
l 
18.8  16.6 
4-2.4  -*6.8 
l 
27.2  20.3 
-4-3.3  -4-5.0 
20.4  20.1 
-.3.1  -4-9.7 
7.9  14.6 
-4-2.6  -*5.0 
* Plus or minus 1 standard deviation. 
differences  observed  were  found  to  be  significant  at  the  0.1  per  cent  level 
p <  0.001). In contrast, the survival of unsensitized red cells (ratio of antiserum  to 
red cells =  0) in normal  and cortisone-treated  recipients at 3  hours was identi- 
cal  (93  per  cent).  Although  this figure is somewhat  lower than  anticipated,  it 
supports  the  validity  of  the  relative  percentages  employed  to  estimate  blood 
volume  in the two groups of animals  (i.e.,  4.46 and 4.74 per cent). 
The livers of the cortisone-treated  rats were heavier, paler in color, and some- 
what  more friable than  their normal  counterparts.  On microscopic examination 
of ultrathin  sections,  4 the liver cells were so distended  with  glycogen  that  the 
We are indebted to  Dr. Leon Weiss, presently in the Department  of  Anatomy, Johns 
Hopkins University School of Medicine, for the preparation of these sections. The tissues were 
fixed in osmium tetroxide,  sectioned to  a  thickness of 2  microns, and  stained with either 
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sinusoids appeared reduced in number and diameter. The hepatic Cr  51 content 
(total and per gram of liver weight) of the cortisone-treated animals was sig- 
nificantly diminished (p  <  0.001) compared with that of the controls (Table 
II, Fig. 2). However, no diminution in hepatic Cr  51 content could be demon- 
strated when steroid-treated animals received normal red cells.  This suggests 
that steroid administration produced no diminution in the intrahepatic vascu- 
lar space. 
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F~G. 1.  The survival of Cr61-1abeled, antibody-treated red cells 3 hours after injection into 
normal (O .... Q) and into cortisone-treated ((D  ©) rats. Each point represents the mean 
of several observations with one standard deviation shown. 
Although the spleens of the cortisone-treated rats were uniformly small, they 
differed histologically from normal only in their reduced content of lymphoid 
tissue with no apparent disturbance of their normal sinusoidal structure.  No 
statistical differences in the splenic accumulation of sensitized red cells could 
be demonstrated between the two groups of animals (Table II, Fig. 3). In con- 
trast to the control animals where, at a given level of red cell sensitization, there 
was  little variation in  splenic  sequestration  (total  and  per  gram  of spleen) 
from animal to animal, these values in the treated rats varied considerably. At 
each level of antiserum employed, the spleens of the cortisonized animals ac- 
tually contained, on the average, greater Cr  51 activity per gram of tissue than MANUEL  F.,  KAPLAN  AND  JAMES  H.  ~ANDL  927 
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FIG. 2.  The hepatic sequestration of CP~-labeled,  antibody-treated red cells  in  normal 
(e ..... e)  and  in  cortisone-treated (0  0)  rats.  Each  point  represents  the  mean  of 
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FIG.  3.  The  splenic sequestration of  Cr61-1abeled, antibody-treated  red  cells in  normal 
(0  ..... O) and cortisone-treated (O  O) rats. Each point represents the mean of several 
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did the controls. This trend was more marked at greater degrees of erythrocyte 
sensitization. 
In none of the steroid-treated animals  was  there significant  accumulation 
(> 1 per cent of injected counts) of Cr  51 activity in the lungs, kidney, or femur. 
A  study was made of the duration of steroid therapy necessary to inhibit 
hepatic sequestration of sensitized red cells. Studies identical with those already 
described were performed in 32 rats, 16 pretreated daily with cortisone acetate 
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DAYS  OF  CORTISONE 
FIo. 4.  The effect of varying periods of cortisone administration on the hepatic sequestra- 
tion of Cr~Llabeled,  antibody-treated red cells in rats. The results are expressed as percentages 
of the mean value in control animals. 
for periods of 1 hour to 4 days, and 16 untreated controls. Each recipient re- 
ceived the same volume of chromated red cells sensitized with a fixed quantity 
of antiserum (ratio antiserum to red ceils -- 0.5) and the hepatic accumulation 
of Cr  "1 activity 3  hours thereafter was measured. The results (which include 
the data from 6 days of cortisone treatment depicted in Table II), expressed as 
the mean percentage of the hepatic Cr  51 activity found in the control animals, 
indicate  that  no  inhibition  could  be  demonstrated  before  the  3rd  day  of 
cortisone  administration  (Fig.  4).  Statistical  analysis  of  these  data  by  the 
method of rank sum tests (34) yield the following measures of significance (p) 
for the various treatment periods: at  2 days 0.557; at 3 days 0.171; at 4 days 
0.014, and at 6 days 0.003. 
-O 930  INHIBITION"  OF  RED  CELL SEQUESTRATION BY  CORTISONE 
2.  Incubated Red Cells.--The organ uptake of Cr 51 from labded red cells that 
had been incubated for 21 hours at 37°C  was determined 3 hours after injection 
in two groups of rats: (a) one group  of 6  animals that had received cortisone 
acetate for 6 days as previously described; another group of 7 animals that had 
received parenteral  injections  of  saline  in  equivalent  volume.  It  was  found 
(Table III) that the percentage of injected Cr 51 activity recovered in the livers 
TABLE III 
The Effect of Cortisone on the Sequestration of Incubated Red Cells 
Normal 
Cortisone 
t 
P 
No. animals 
studied 
Tissue distribution  C#  1, per cent injected, 
3 hrs. postinjection 
Liver 
42.0  4-  10.6 
19.6  4-  11.6 
--3.  628 
0.005  >  p  >  0.001 
Spleen 
33.2  4-  7.2 
33.3  4-  5.7 
0.0274 
p  >  0.90 
TABLE IV 
The Effect of Cortisone on the Sequestration of Hemoglobin 
Normal 
Cortisone 
t 
P 
No. animals 
studied 
6 
6 
Tissue distribution  Cr  .1, per cent injected, 
3 hrs. postinjection 
Liver  Spleen 
22.1  -4- 3.4 
20.5  .4- 4.1 
--0.738 
0.50  >  p  >  0.40 
2.8  -4- 0.2 
2.3  -4- 0.5 
-- 1.897 
0.10  >  p  >  0.05 
of the control animals (42.0 4- 10.7 per cent) greatly exceeded that found in the 
steroid-treated group (19.6 4- 11.6 per cent)--0.005  >  p  >  0.001. In contrast, 
the  spleens  of  the  two  groups  of  animals  took  up  the  same  amount  of 
Cr61-1abeled cells (controls: 33.2 4- 7.2 per cent vs. cortisone-treated: 33.3 4- 5.7 
per cent)--p >  0.9. 
3.  Hemoglobin.--The  organ  distribution  of  CrSl-labeled  hemoglobin  was 
studied in 12 rats; 6 had received cortisone acetate intramuscularly for 6 days 
as previously described and 6 had received saline. The results, depicted in Table 
IV, indicate that the hepatic sequestration of hemoglobin was unimpaired in 
cortisonized rats.  Only minor  differences  were  noted  in  the  Cr  51  uptakes  of 
other organs in the two groups of animals. MANUEL  ~.  KAPLAN AND  JAMES  H.  JANDL  931 
DISCUSSION 
Several investigators have studied the effects of adrenocortical steroids on 
experimentally  induced  hemolytic anemias  in  animals  (36-40).  In  most  in- 
stances heterologous antisera, presumably containing hemolysins, were injected 
directly into control and steroid-treated animals  and no significant  ameliora- 
tion of the hemolytic processes was observed. These reports have led to the con- 
clusion that, in acquired hemolytic anemia, adrenal steroids must act primarily 
to suppress antibody synthesis. Certain objections to this conclusion  may be 
raised: (a) Steroid-induced remissions in acquired hemolytic anemias may occur 
so rapidly (within a few days)  that it is difficult to accept suppression of anti- 
body synthesis as the primary effect of such therapy; (b) in man, suppression of 
antibody synthesis by cortisone has not yet been conclusively demonstrated 
(41-46), and  (c) often no appreciable diminution in red cell sensitization  (as 
measured by the antiglobulin titer) occurs early in cortisone-induced remission 
(47). On the other hand,  these objections are not necessarily insurmountable. 
For example,  the numerous reports indicating that administration  of adreno- 
cortical steroids diminishes  antibody production in a variety of species make it 
likely that this also occurs in man. Further,  the observed effects of a modest 
reduction in antibody synthesis in a situation involving rapid consumption of 
antibody (as may be the case in immunohemolytic anemias) might be sudden 
and dramatic.  Finally, the "measurement" of antibody adsorbed to red cells 
by the antiglobulin titration method is theoretically unsound, and the results 
obtained by measuring the protein which can be eluted from red cells may be 
difficult  to interpret  (48). 
The present studies were initiated not to disprove the possibility that corti- 
sone may inhibit antibody synthesis but to establish whether cortisone affects 
the sequestration of red cells altered in vitro in a standardized fashion. 
The  data here presented indicate  that  cortisone retards  the sequestration 
of antibody-sensitized and of incubated red cells by the liver. The mechanism 
of this effect is unknown at present. It cannot derive from a  specific action of 
steroids on immune processes since the  sequestration of cells injured by non- 
immunologic techniques was similarly inhibited. 
Among the possible explanations to be considered are: 
1.  Modification of Intrahepatic Blood Flow.--It has long been recognized that 
administration of adrenocortical steroids to animals causes prompt accumula- 
tion of glycogen in liver cells (49). Ingle et al. (50), studying the time-response 
effect of cortisone (in doses comparable to those utilized in this study) on liver 
glycogen in the rat, found that glycogen accumulates  rapidly within the first 
few days, reaches peak levels by 5 days, and slowly diminishes thereafter. In the 
rat, as in other species (51),  this accumulation of glycogen causes attenuation 
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hepatic blood flow. Indeed, if this were not the case, the maintenance of normal 
volume flow would require either an increased flow rate  through  constricted 
channels  or the opening of intrahepafic shunts.  In either event the perfusing 
red cells might  be subjected less  to intrahepatic  stasis and  to the action of 
phagocytic Kupffer cells lining the hepatic sinusoids. As yet, however, there is 
insufficient information regarding the effects of cortisone on hepatic blood flow 
to warrant further discussion. 
2.  Inhibition  of Phagocytosis.--There  are similarities  between the sequestra- 
tion of altered red cells and the clearance of colloidal substances (foreign par- 
tides, bacteria, denatured proteins, etc.) from the blood by the reticuloendo- 
thelial system (12, 52). Thus, it has been demonstrated that stable colloids (53), 
lightly opsonized bacteria (54),  and red cells lightly sensitized  with antibody 
(31) are sequestered relatively slowly, principally by the spleen; unstable col- 
loids, more intensely opsonized bacteria, and more heavily sensitized  red cells 
are sequestered relatively rapidly, primarily by the liver.  It has been reported 
that adrenocortical steroids impede phagocytosis in general  (55-58)  and phago- 
cytosis by Kupffer cells in particular  (59),  although other investigators have 
denied  such  effects  (60-64).  Consequently,  basic  disagreement  still  exists 
whether steroids affect the clearance from the blood of intravenously injected 
bacteria or colloids (65-68). To date, there has not been enough information ob- 
tained in vivo to distinguish between possible local vascular effects of adreno- 
cortical steroids and their alleged action as inhibitors of phagocytosis. For ex- 
ample,  Nicol and  Bilbey (58)  observed that  cortisone administration  slowed 
the clearance of intravenously administered colloidal carbon in mice. This was 
accompanied, histologically,  by diminished  accumulation of carbon within the 
liver. These observations, which are quite analogous to ours, may be interpreted 
as  demonstrating  either  direct  inhibition  of phagocytosis  by cortisone  or 
indirect interference with reticuloendothelial function secondary to cortisone- 
induced vascular changes within the liver.  Recently Packer  et al.  (69)  have 
presented convincing evidence gathered in vitro that steroids impair erythropha- 
gocytosis by leukocytes. In the present study, however, histiologic examination 
of ultrathin sections of liver from normal rats obtained at various times after 
infusion of sensitized  red cells revealed principally intrasinusoidal  clumping of 
cells with very little evidence of  phagocytosis as the red cells were being seques- 
tered. Consequently it is unlikely that the inhibitory effect of cortisone upon 
hepatic sequestration is due to erythrophagocytosis. Furthermore, it would be 
difficult to explain why sequestration was impaired only in the liver if owing to 
the suppression of a general mechanism (i.e., phagocytosis). 
3.  Impairment of Hemoglobin Capture by the Liver.--It is  conceivable that, 
after infusion of altered red cells into cortisone-treated rats, hepatic sequestra- 
tion and red cell destruction proceed normally but that abnormal amounts of 
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excluded by the studies showing that  the livers of cortisonized rats  took up 
Cra-labeled  hemoglobin normally. 
In  several respects,  the  experimental findings reported here are in accord 
with past  dlnical  experience with  steroids in acquired hemolytic states.  (a) 
There is usually a latent period of a few days' duration between the onset of 
therapy and hematologic improvement.  ~ (b)  A number of patients have been 
reported (72)  who failed to benefit  from splenectomy but who subsequently 
were improved by steroids. This indicates that any effect cortisone may have 
on the  spleen is not  essential  to its  therapeutic action.  Indeed,  the  efficacy 
of steroid therapy tends to correlate inversely with the results of splenectomy 
in given patients  (72).  (c)  Although few  appropriate studies have been con- 
ducted in man, in at least two reported cases (in reference 21, case 10; and in 
reference  73,  case  23)  cortisone-induced  remissions  have  been  associated 
primarily with a  reduction in the hepatic,  rather than the splenic, uptake of 
autogenous, Cr51-1abeled red cells. 
It is hoped that further studies in animals and man will clarify the funda- 
mental  action of cortisone in inhibiting red  cell sequestration and so direct 
future approaches to therapy. 
SU'MMARY 
The effect of cortisone on the  sequestration of (a) antibody-coated red cells 
and  (b)  incubated  red  ceils  was  studied  in  rats.  Cortisone  admln~stration 
inhibited the hepatic sequestration of red cells altered by non-immune as well 
as by immune injury. There was a latent period of 2 days between the institu- 
tion of cortisone therapy and its first manifest effect on hepatic sequestration. 
The splenic sequestration of altered red cells was not inhibited by cortisone, 
and there was no inhibition of the sequestration of hemoglobin by either liver 
or spleen. 
It  is  suggested  that  steroids  may  inhibit  hepatic  sequestration  through 
hemodynamic effects. 
The authors wish to  express  their appreciation to  Mrs.  Laurie A.  Dancy for technical 
assistance. 
BIBLIOGRAPHY 
1.  Gardner, F. H., McElfresh, A. E., Harris, J. W., and Diamond, L. K., The effect 
of adrenocorticotrophic hormone  (ACTH)  in  idiopathic acquired hemolytic 
anemias as related to hemolytic mechanisms, J. Lab. and Clin. MeA., 1951, 37, 
444. 
Previous reports that cortisone (70) or prednisolone (71) had no suppressive effect on 
experimental hemolysis by isoanfibodies  in man are presumably explained by the fact that 
the steroids were administered for an insuflident length of time (48 hours or less) to affect 
sequestration. Although short-term administration of cortisone did not affect the extent of 
hemolysis or leukopenia, it did block the febrile reaction to immune hemolysis (70, 71). 934  INHIBITION  OF  RED  CELL SEQUESTRATION BY  CORTISONE 
2.  Dameshek,  W., Rosenthal, M. C., and Schwartz, L. I., The treatment of acquired 
hemolytic anemia  with adrenocorticotrophic hormone  (ACTH), New England 
J. Med., 1951, 244, 117. 
3.  Davidson,  L. S.  P., Duthie, J. J. R.,  Girdwood, R. H., and Sinclair, R. J.  G., 
Clinical trials of ACTH in haemolytic anaemia, Brit. Med. ]., 1951, 1,657. 
4.  Wintrobe, M. M., Cartwright,  G. E., Palmer, J. G., Kuhns, W. J., and Samuels, 
L. T., Effect of corticotrophin and cortisone on the blood in various disorders 
in man, Arch. Int. Meal., 1951, 88, 310. 
5.  Meyers, M. C., Miller, S., Linman,  J. W., and Bethell, F. H., The use of ACTH 
and cortisone in idiopathic  thrombocytopenic purpura and idiopathic  acquired 
hemolytic anemia, Ann. Int. Med., 1952, 3/, 352. 
6.  Dameshek,  W., and Komninos, Z. D., The present status of treatment of auto- 
immune hemolytic anemia with ACTH and cortisone, Blood, 1956, 11,648. 
7.  Davis, L. J., Kennedy, A. C., Baikie, A. G., and Brown, A., Haemolytic anaemias 
of various types treated with ACTH and cortisone, Glasgow Med. J., 1952, 33, 
263. 
8.  Medical Research  Council Haematology Panel, The treatment of blood disorders 
with ACTH and cortisone, Brit. Meal. J., 1952, 1, 1261. 
9.  Coleman, D. H., and Finch, C. A., Effect of adrenal steroids in hereditary sphero- 
cytic anemia, J. Lab. and Clin. Med., 1956, 4/, 602. 
10.  Muirhead,  E. E., Graves, M., and Bryan, S., Positive direct Coombs test induced 
by phenylhydrazine, J. Clin. Inv., 1954, 33, 1700. 
11.  Sutherland,  D. A., and Eisentraut, A. M., The direct Coombs test in lead poison- 
ing, Blood, 1956, 11~ 1024. 
12.  Jandl, J. H., and Simmons, R. L., Agglutination  and sensitization  of red cells by 
metallic cations, Brit. J. Haematol., 1957, 3, 19. 
13.  Jandl, J. H., The agglutination  and sequestration of immature red cells, J. Lab. 
and Clin. Med., 1960, 55, 613. 
14.  Harris, J.  W.,  Studies  on the mechanism  of a drug-induced  hemolytic anemia, 
J. Lab. and Clin. Med., 1956, 47, 760. 
15.  Freedman, A. L., Barr, P. S., and Brady, C. A., Hemolytic anemia due to quini- 
dine: observations  on its mechanism, Am. J. Med., 1956, 20, 806. 
16.  Weiner,  W.,  Battey, D.  A.,  Cleghorn,  T. E., Marson,  F.  G. W.,  and Meynell, 
M. N., Serologic findings in a case of haemolytic anaemia  with some general 
observations on the pathogenesis of the syndrome, Brit. Med. J., 1953, 9., 125. 
17.  Dacie, J. V., and Cutbush, M., Specificity of autoantibodies in acquired haemolytic 
anaemia, J. Clin. Path., 1954, 7, 18. 
18.  van Loghem, J. J., and van der Hart, M., Varieties of specific auto-antibodies in 
acquired haemolytic anaemia,  Vex Sang.,  1954, 4, 2. 
19.  Wiener, A. S., Unger, L. J., Cohen, L., and Feldman,  J., Type-specific cold auto- 
antibodies  as a cause of acquired hemolytic anemia  and hemolytic transfusion 
reactions, Ann. Int. Med., 1956, 44, 221. 
20.  Green,  H.,  Barrow,  P.,  and  Goldberg,  B.,  Effect of antibody on permeability 
control in ascites tumor cells and erythrocytes, J. Exp. Med., 1959, 110, 699. 
21.  Jandl, J.  H.,  Greenberg,  M.  S., Yonemoto,  R.  H., and  Castle,  W.  B.,  Clinical 
determination of the sites  of red cell sequestration in hemolytic anemias,  J. 
Clin. Inv., 1956, 35, 842. MANUEL  E.  KAPLAN AND  IAMES  H.  IANDL  935 
22.  Jandl, J. H., Jones, A. R., and Castle, W. B., The destruction of red cells by anti- 
bodies in man. I. Observations on the sequestration and lysis of red cells altered 
by immune mechanisms, Y. Clin. Inv., 1957, 36, 1428. 
23.  BjCrneboe, M.,  Fischel,  E. E.,  and Stoerk, H.  C., The effect of cortisone  and 
adrenocorticotrophic hormone on  the  concentration of circulating  antibody, 
J. Exp. Med., 1951, 93,  37. 
24.  Kass, E. H., and Finland, M., Adrenocortical hormones in infection and immunity, 
Ann. Rco. Microbiol., 1953, 7, 361. 
25.  Davidsohn,  I.,  and  Spurrier,  W.,  Immunohematological  studies  in  hemolytic 
anemia, J. Am. Med. Assn., 1954, 154, 818. 
26.  Creger, W. P., Tulley, E. H., and Hansen, D. G., A note on the effect of hydro- 
cortisone on the microelectrophoretic  characteristics  of human red cell-antibody 
unions, J. Lab. and Clin. Med., 1956, 4V, 686. 
27.  Leahy, R. H., and Morgan, H. R., The inhibition of cytotoxic activity of PPD on 
tuberculin-hypersensitive  cells in tissue culture, J. Exp. Mat., 1952, 96, 549. 
28.  Kerby, G. P., and Barrett, J. A., The effect of hydrocorfisone and of piromen on 
leukocytes of patients receiving ACTH and cortisone,  J. CUn. Inv., 1954, 33, 
725. 
29.  Marmont, A. M., and Fusco, F. A., Perspectives  on the role of the RES in the 
steroid-induced  remissions of auto-immune blood disorders with special regard 
to acquired hemolytic anemias, in Reticuloendothelial  Structure and Function 
(J. H. Heller, editor), New York, The Ronald Press Co., 1960, 373--402. 
30.  Kaplan, M. E., Studies of the mechanism of action of cortisone on red cell destruc- 
tion, Clin. Research, 1960, 8, 211 (abstract). 
31.  Jandl, J. H., and Kaplan, M. E., The destruction of red cells by antibodies in man. 
III. Quantitative factors influencing the patterns of hemolysis in vivo, J. Clin. 
Inv., 1960, 39, 1145. 
32.  Coombs, R. R. A., Mourant, A. E., and Race, R. R., A new test for the detection 
of weak and "incomplete" Rh aggintinins, Brit. J. Exp. Path., 1945, 26, 255. 
33.  Jandl,  J.  H., and  Castle,  W.  B.,  Agglutination  of sensitized  red cells by large 
anisometric molecules, J. Lab. and Clin. Med.,  1956, 47, 669. 
34.  Dixon, W. J., and Massey,  F. J., Jr., Introduction to Statistical Analysis, 2nd 
edition, New York, McGraw-Hill Book Co., Inc., 1957. 
35.  Stevens,  W. H., Statistical analysis of a non-orthogonal  tri-factorial experiment, 
Biometrica, 1958, 35, 346. 
36.  Palmer, J.  G.,  Cartwright,  G.  E., and Wintrobe, M.  M., The effect of ACTH 
and cortisone  on the blood of experimental animals,  Proc. 2nd  Clin.  ACTtt 
Conf., 1951, 1, 438. 
37.  Clearkin,  K.  P.,  Effect of adrenocorticotropic hormone on clinical and experi- 
mental haemolytic anaemia,  Lancet, 1952, 1, 183. 
38.  Tischendorf,  W.,  Ecklebe,  G.,  and  Thofern, E.,  ACTH und  experimentellen 
hemolytische An~mien, Zeit. ges. exp. Med., 1952, 118, 203. 
39.  Feldman, J. D.,  and Rachmilewltz,  M., The adrenal cortex and hemolysis. II. 
Immune hemolysis, Acta Haematol., 1954, 11,  129. 
40.  Baikie, A. G., and Piffle, R., The effects of ACTH and cortisone in experimental 
hacmolytic anaemias in guinea pigs, Scot. Med. J., 1958, 3, 264. 936  INHIBITION OF  RED CELL SEQUESTRATION BY  CORTISONE 
41.  Mirick,  G. S., The effect of ACTH and cortisone on antibodies in human beings, 
Bull. Johns Hopkins  Hosp.,  1951, 88, 332. 
42.  Hahn, E. O., Houser, H. B., Rammelkamp, C. H., Jr., Denny, F. W., and Wanna- 
maker, L.  W.,  Effect of cortisone on acute streptococcal infections and  post- 
streptococcal complications. J. Clin. Inv., 1951, 30, 274. 
43.  Larsen,  D.  L.,  and  Tomlinson,  L.  J.,  Quantitative  antibody  studies  in man.  I. 
The effect of adrenal insufficiency and  of cortisone on the level of circulating 
antibodies, J. Clin. Inv., 1951, 30, 1451. 
44.  Havens, W. P., Jr., Shaffer, ]. M., and Hopke, C. J., Jr., The effect of ACTH and 
cortisone on the concentration of circulating diphtheria antitoxin, J. Immunol., 
1952,  68, 389. 
45.  Freedman, H. T., The influence of cortisone and hydrocortisone on the production 
of circulating antibody in human beings, J. Allergy, 1953, 24, 342. 
46.  Kunin, C. M., Schwartz, R., Yaffee, S., Knapp, J., Fellers, F. X., Janeway, C. A., 
and Finland, M., Antibody response to influenza virus vaccine in children with 
nephrosis: effect of cortisone, Pediatrics, 1959, 23, 54. 
47.  Dacie, J. V., The Haemolytic Anaemias, New York, Grune & Stratton, 1954. 
48.  Fudenberg, H., Barry, I., and Dameshek, W., The erythrocyte-coating substance 
in autoimmune hemolytic disease: its nature and significance, Blood, 1958,  13, 
201. 
49.  Long, C. N. H., Katzin, B., and  Fry, E., The adrenal cortex and carbohydrate 
metabolism, Endocrinology, 1940, 26, 309. 
50.  Ingle, D. J., Meeks,  R.  C., and Beary, D.  F., Time-response effect of cortisone 
upon liver glycogen in the rat, Proc. Soc. Exp. Biol. and Meal., 1953, 84, 239. 
51.  Shewell,  J.,  and  Long,  D.  A.,  A  species difference with  regard  to  the  effect of 
cortisone acetate  on body weight,  gamma globulin,  and  circulating  antitoxin 
levels, J. Hygiene,  1956, 54, 452. 
52.  Miescher, P., Le m6chanisme de erythroclasie a l'etat normal,  Revue d' Hemdto- 
logie, 1956, 11,248. 
53.  Dobson,  E.  L.,  Factors  controlling  phagocytosis,  in  Physiopathology  of  the 
Reticuloendothelial  System,  (B.  N.  Halpern,  editor),  Springfield,  Illinois, 
Charles C Thomas Co., 1957, 80. 
54.  Benacerraf, B., Sebestyen, M. M., and Schlossman, S., A quantitative study of the 
kinetics  of  blood  clearances  of  P~-labelled  E.  coli and  Staphylococci by  the 
reticuloendothelial system, J. Exp. Med.,  1959, 110, 27. 
55.  Crepea, S. B., Magnin,  G. E., and Seastone, C. V., Effect of ACTH and cortisone 
on phagocytosis, Proc. Soc. Exp. Biol. and Med.,  1951, 77, 704. 
56.  Rebuck, J. W., and Mellinger, R. C., Interruption by topical cortisone of leuko- 
cyte cycles in acute inflammation in man, Ann. New York Acad. Sc.,  1953, 56, 
715. 
57.  Heller, J. H., Cortisone and phagocytosis, Endocrinology, 1955, fi6, 80. 
58.  Nicol, T., and Bilbey, D. L. J., The effect of various steroids on the phagocytic 
activity of the reticuloendothelial system, in Reticuloendothelial Structure and 
Function (J. H. Heller, editor), New York, The Ronald Press Co., 1960. 
59.  Heller, ].  H., Effect of cortisone on  the function,  capacity,  and  activity of the 
reticuloendothelial system, Fed. Proc., 1953, 12, 65,  (abstract). MANUEL E.  KAPLAN AND JA~ES H.  JANDL  937 
60.  Benacerraf, B., Halpern, B. N., Biozzi, A., and Benos, S. A., Quantitative study 
of the granulopectic  activity of the reticuloendothelial  system. III. The effect 
of cortisone and nitrogen mustard on the regenerative capacity of the R.E.S. 
after saturation with carbon, Brit. 2. Exp. Path.,  1954, 85, 97. 
61.  GeU, P. G. H., and Hinde, I. T., The effect of cortisone on macrophage  activity 
in mice, Brit. J. Exp. Path., 1953, 84, 273. 
62.  Magee,  P.  N., and Palmer, A.  A., The absorption of particles  from  the  peri- 
toneal cavity in rats and mice treated with cortisone,  Brit. J. Exp. Path., 1953, 
84, 458. 
63.  Reichard, S. M., Edelmann, A., and Gordon, A. S., Endocrine influence upon the 
uptake of colloidal thorium by the reticuloendothelial  system, J. Lab. and Clin. 
Med., 1956,48, 431. 
64.  Hirsch, J.  G., and Church,  A. B., Adrenal  steroids  and infection: The effect of 
cortisone  administration on polymorphonuelear leukocytic functions  and on 
serum opsonins and bactericidins, J. Clin. In~., 1961, 40,794. 
65.  White, R. G., and Marshall,  A. H. E., Effect of cortisone on pneumococcal bac- 
teremia, Lancet,  1951, 1, 891. 
66.  Germuth, F. G., Jr., Ottinger, B., and Oyama, J., The influence of cortisone on the 
evolution of acute infection and  the development of immunity, Bull. Johns 
Hopkins Hosp., 1952, 91, 22. 
67.  Martin, S. P., and Kerby, G. P., Effect of adrenal hormone overdosage on bac- 
terial removal by the splanchnic viscera, Proc. Soc. Exp. Biol. and Med.,  1952, 
81, 73. 
68.  Rogers, D. E., and Melly, M. A., Studies on bacteremia. II. Further observations 
on  the  granulocytopenia induced by intravenous injection of staphylococci. 
J. Exp. ivied., 1957, 105, 99. 
69.  Packer, J. T., Greendyke,  R. M., and Swisher, S. N., The inhibition of erythro- 
phagocytosis in vitro by corficosteroids, Tr. Assn. Am. Physn.,  1960, 78, 93. 
70.  Jandl, J. H., and Tomlinson,  A. S., The destruction of red cells by antibodies  in 
man.  II.  Pyrogenic, leukocytic and  dermal responses  to immune hemolysis, 
J. Clin. Inv., 1958, 37, 1202. 
71.  Hewitt, W. C., Wheby, M., and Crosby, W. H., Effect of prednisolone on incom- 
patible blood transfusions,  Transfusion,  1961, 1, 184. 
72.  Chertkow, G., and Dacie, J. V., Results of splenectomy in autoimmune haemolytic 
anaemia, Brit. J. Haematol., 1956, 2, 237. 
73.  Lewis, S. M., Szur, L., and Dacie, J. V., The pattern of erythrucyte destruction 
in haemolytic anaemia,  as studied with radioactive chromium, Brit. J. Haema- 
tot., 1960, 6, 122. 